Press Releases

Mr. Leong brings with him a wealth of scientific and regulatory experience Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind, is pleased to announce …

HAVN Life Announces Gary Leong’s Appointment to Board of Directors Read More »

The Subscription-based Functional Mushroom Company has established a significant consumer base in the U.S. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company developing natural health products and innovative therapies to support central nervous system health and enhance the capabilities of the mind, …

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc. Read More »

The Company was able to export naturally derived psilocybin to their California-based Supply Partner, Mycrodose Therapeutics late last week. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential active pharmaceutical ingredients (APIs) …

HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes Read More »

The Company Signs Supply Agreement with Nectar Health Sciences Laboratory Division Inc. to provide naturally derived psilocybin for research and development of therapeutic products Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of …

HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada Read More »

The Agreement gives Woke Pharmaceuticals exclusive White Label and Distribution rights to HAVN Life products in Australia, New Zealand and China through retail and e-commerce portals Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to …

HAVN Life Enters into Agreement to Distribute its Line of Natural Health Products with Australia’s Woke Pharmaceuticals Read More »

Along with adding new formulations to the Company’s natural health product portfolio, founder Matthew Bennett to join HAVN Life as Director of Education Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”)a biotechnology company developing natural health products and innovative therapies to support brain health and …

HAVN Life Acquires Bennett’s Choice Patented Brain Health and Recovery Formulations Read More »

The partnership is a integral step in the The Company’s path to market in the U.S., achieving one of its most important milestones to-date Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”)a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs …

HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics Read More »